The world's political record
Records whose title is actually about this topic. Use a country filter if the list is still too broad.
951 records in US in 2022
United States · United States Congress · 9 February 2022
This resolution expresses support for the goals of Heart Valve Disease Awareness Day.
United States · United States Congress · 9 February 2022
Critical Access Hospital Relief Act of 2022 This bill repeals the 96-hour physician-certification requirement for inpatient critical access hospital services under Medicare. Under current law, as a condition for Medicare payment for such services, a physician must certify that a patient may reasonably be expected to be discharged or transferred to a hospital within 96 hours after admission to the critical access hospital.
United States · United States Congress · 9 February 2022
Health Care for Burn Pit Veterans Act This bill updates policies and procedures related to Department of Veterans Affairs (VA) health care and benefits for veterans who have been exposed to toxic substances. Specifically, the bill extends the eligibility period for VA hospital care, medical services, and nursing home care for combat veterans who served after September 11, 2001, and were exposed to toxic substances, radiation, or other conditions, including those who did not enroll to receive VA care during the eligibility period. The VA must incorporate into its existing health care screening a screening to help determine potential exposures to toxic substances during military service. Among other requirements, the VA must also provide annual training to health care and benefits personnel with respect to veterans who were exposed to toxic substances; analyze total and respiratory disease mortality in veterans who served in specified locations on specified dates; conduct an epidemiological study on the health trends of veterans who served in the Armed Forces after September 11, 2001; conduct a study to determine trends in the rates of the incidence of cancer in veterans; publish a list of VA resources for veterans who were exposed to toxic substances, families and caregivers of such veterans, and survivors of such veterans who are receiving death benefits; and report on the data quality of the Individual Longitudinal Exposure Record and its usefulness in supporting veterans in receiving VA health care and benefits.
United States · United States Congress · 9 February 2022
Provider Relief Fund Improvement Act This bill extends deadlines, expands the uses of, and makes other changes pertaining to the Provider Relief Fund. The fund reimburses health care providers for increased expenses or lost revenue attributable to COVID-19. Specifically, the bill extends the deadline by which providers must use any reimbursements they received in 2020 from the fund to the end of the COVID-19 emergency. Providers must use reimbursements received in the first half of 2021 by the end of the emergency or June 30, 2022, whichever is later. Additionally, the Department of Health and Human Services must distribute the remaining provider relief funds by March 31, 2022. Providers must use these funds by June 30, 2023. The bill also allows the use of the funds for workplace safety activities, such as hiring additional security personnel.
United States · United States Congress · 9 February 2022
Health Data Use and Privacy Commission Act This bill temporarily establishes a commission with members appointed through the Government Accountability Office to study and report on issues related to protecting individual privacy while advancing the use of personal health information. The study must address, for example, the use of personal health information by federal, state, and local governments for public health activities and the various statutory and regulatory requirements that apply to such information. In addition, the bill restricts the commission's use and disclosure of any personal health information or proprietary business and financial information obtained in conducting the study. The commission must report its findings, conclusions, and recommendations (as well as those of any dissenting members of the commission) for balancing privacy protections and the appropriate use of personal health information. The commission terminates 30 days after submitting its final report.
United States · United States Congress · 9 February 2022
Cutting Medicare Prescription Drug Prices in Half Act This bill caps the cost of prescription drugs under Medicare at the amount that the Department of Veterans Affairs or the General Services Administration pays for the drug, whichever is lower.
United States · United States Congress · 9 February 2022
This resolution honors the memories of the victims killed in the attack on February 14, 2018, at Marjory Stoneman Douglas High School in Parkland, Florida, and offers condolences to the families, loved ones, and friends of the victims. The resolution (1) honors the survivors and pledges continued support for their recovery, (2) recognizes the strength and resilience of the Marjory Stoneman Douglas High School community, and (3) expresses gratitude to the emergency medical and health care professionals of the Parkland community for their efforts in responding to the attack and caring for the victims and survivors.
United States · United States Congress · 8 February 2022
This bill expands eligibility for Department of Veterans Affairs (VA) reimbursement of emergency treatment for veterans who are treated in a non-VA facility. Specifically, the bill waives the requirement that a veteran must have received VA care within the 24-month period preceding the furnishing of emergency treatment if the veteran receives such emergency treatment within the 60-day period following their enrollment in the VA health care system.
United States · United States Congress · 8 February 2022
CHIP School Behavioral Health Incentive Act This bill excludes expenditures relating to initiatives for school behavioral health services from the administrative spending cap under the Children's Health Insurance Program (CHIP). Currently, states may use up to 10% of their total federal CHIP expenditures on outreach, health services initiatives, and certain other activities (i.e., nonbenefit expenditures). The bill excludes health services initiatives relating to school behavioral health services from this limitation; expenditures for these and other nonbenefit expenditures may not exceed 15% of total expenditures.
United States · United States Congress · 8 February 2022
This concurrent resolution expresses support for a congressional investigation of Dr. Anthony Fauci for corrupt activities and misinformation related to the COVID-19 pandemic. It also supports reducing his salary to $0.
United States · United States Congress · 8 February 2022
DMEPOS Relief Act of 2022 or the DRA of 2022 This bill increases payment adjustments for certain items that were included in Round 2021 of the Medicare Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Competitive Bidding Program but for which contracts were not executed. The bill applies to items that are furnished between January 1, 2022, and December 31, 2023, and that were not subject to the unadjusted fee schedule amount as of January 1, 2021. Under the DMEPOS Competitive Bidding Program, the Centers for Medicare & Medicaid Services (CMS) sets payment for certain durable medical equipment under Medicare based on a competitive bidding process with suppliers, rather than the fee schedule amount. The CMS included 16 product categories in Round 2021 of the program but ultimately did not award contracts for 13 of these categories (that were also in previous rounds) as the resulting payment amounts did not achieve expected savings.
United States · United States Congress · 8 February 2022
Telehealth Extension and Evaluation Act This bill expands and otherwise modifies coverage of telehealth services under Medicare until two years after the end of the COVID-19 public health emergency. Specifically, the bill (1) allows federally qualified health centers and rural health clinics to serve as the distant site (i.e., the location of the health care practitioner), (2) allows for Medicare payment of outpatient critical access hospital services consisting of telehealth behavioral therapy, (3) conditions payment for certain high-cost laboratory tests and durable medical equipment that are ordered via telehealth on at least one in-person visit during the preceding 12-month period, and (4) allows Schedule II through V controlled substances to be prescribed online if a practitioner has conducted a telehealth evaluation with video. The bill also generally extends any Medicare telehealth flexibilities that were granted during the COVID-19 public health emergency until two years after the emergency ends. The Centers for Medicare & Medicaid Services (CMS) must report on the effects of changes that were made during the emergency period with respect to the provision or availability of telehealth services under Medicare. The CMS must also award grants to state Medicaid programs to allow them to report on similar information.
United States · United States Congress · 8 February 2022
Veterans Health Care Freedom Act This bill requires the Center for Innovation for Care and Payment within the Department of Veterans Affairs (VA) to implement a three-year pilot program to improve the ability of veterans who are enrolled in the VA health care system to access hospital care, medical services, and extended care services through the covered care system by providing such veterans with the ability to choose health care providers. Under the bill, the covered care system includes VA medical facilities, health care providers participating in the Veterans Community Care Program (VCCP), and eligible entities or providers that have entered into a Veterans Care Agreement. A veteran participating in the program may elect to receive care at any provider in the covered care system. The pilot program removes certain requirements (e.g., location of the veteran) to access care at VA and non-VA facilities. After four years, the bill eliminates the requirements for accessing care under the VCCP and Veterans Care Agreements and requires the VA to provide such care under the same conditions of the pilot program. Additionally, after four years, veterans may receive care at a VA medical facility regardless of whether the facility is in the same Veterans Integrated Service Network as the veteran.
United States · United States Congress · 7 February 2022
Medicaid Third Party Liability Act This bill modifies requirements relating to Medicaid third-party liability. Current law generally requires legally liable third parties (e.g., health insurers) to pay claims before Medicaid. However, Medicaid must pay first (and seek reimbursement from liable third parties) for claims for (1) preventive pediatric care, and (2) services for an individual for whom child support enforcement is being conducted by the state. The bill repeals these exceptions. Current law also requires state Medicaid programs to take all reasonable measures to identify legally liable third parties. The bill specifically prohibits federal Medicaid payment for services to individuals for whom third-party insurance information was not obtained and verified by the state.
United States · United States Congress · 7 February 2022
Due Process Continuity of Care Act This bill allows an otherwise eligible individual who is in custody pending disposition of charges (i.e., pretrial detainees) to receive Medicaid benefits at the option of the state. The bill also provides funds for state planning grants to support the provision of such benefits.
United States · United States Congress · 7 February 2022
This bill makes permanent the authority of the Department of Health and Human Services (HHS) to appoint personnel to the National Disaster Medical System for intermittent disaster response. (This system is a partnership between HHS, the Department of Defense, the Department of Homeland Security, and the Department of Veterans Affairs that responds to public health and other emergencies.)
United States · United States Congress · 7 February 2022
Equal Access to Therapeutics Act This bill prohibits using race or ethnicity as a factor in decisions about an individual's access to COVID-19 treatments (e.g., monoclonal antibody therapies). Specifically, the Department of Health and Human Services (HHS) may not adopt any policy or guidance that allows race or ethnicity to be factored into such decisions. Furthermore, the Secretary of HHS shall be personally liable for the death of any individual who is denied access to COVID-19 treatments pursuant to a prohibited policy or guidance. The bill also prohibits hospitals or other health care providers that have policies restricting access to COVID-19 treatments based on race or ethnicity from receiving federal funds.
United States · United States Congress · 7 February 2022
This resolution supports the designation of National Burn Awareness Week.
United States · United States Congress · 7 February 2022
Medical Countermeasures Surge Capacity Act of 2022 This bill expands the scope of research and development activities carried out by the Biomedical Advanced Research and Development Authority (BARDA) to include support for maintaining and improving domestic manufacturing surge capacity and capabilities for vaccines, diagnostics, and other medical countermeasures. In particular, BARDA must enter into transactions with facilities to ensure that domestic manufacturing surge capacity is available to manufacture medical countermeasures and related products in the event of a public health emergency (e.g., by supporting flexible or advanced manufacturing). The Government Accountability Office must report on these efforts. In addition, BARDA must address support for domestic manufacturing surge capacity in its strategic plan for countermeasure research, development, and procurement. The bill also reauthorizes through FY2028 a program through which BARDA may support innovative technologies to assist in medical countermeasure research and development using grants, cooperative agreements, and other transactions.
United States · United States Congress · 4 February 2022
This resolution condemns workplace violence and harassment against health care personnel.
United States · United States Congress · 4 February 2022
This concurrent resolution expresses the sense of Congress that the federal government should ensure access to appropriate end-of-life care and discourage adoption of policies or practices supporting assisted suicide.
United States · United States Congress · 4 February 2022
This resolution expresses support for the goals and ideals of National Black HIV/AIDS Awareness Day.
United States · United States Congress · 4 February 2022
Advancing Maternal Health Equity Under Medicaid Act This bill provides a 90% federal matching rate for Medicaid maternal health care expenditures that exceed 2021 levels. Qualifying services must be provided by maternity care providers or perinatal health workers (e.g., doulas) and include prenatal and postpartum telehealth services, home visits, and behavioral health care.
United States · United States Congress · 4 February 2022
This resolution expresses support for the designation of National Cancer Prevention Day.
United States · United States Congress · 4 February 2022
Affordable Housing Resident Services Act of 2022 This bill requires the Department of Housing and Urban Development to award competitive grants to owners of federally-assisted affordable housing for specified resident assistance activities, including obtaining health care, enhancing economic self-sufficiency, and assisting older adults and residents with disabilities.
United States · United States Congress · 3 February 2022
This resolution expresses support for the recognition of American Heart Month to bring awareness to the cardiovascular disease public health crisis in the United States and abroad.
United States · United States Congress · 3 February 2022
Diverse and Equitable Participation in Clinical Trials Act or the DEPICT Act This bill requires applications for an investigational use exemption of a new drug or medical device to include information about the demographic diversity of the clinical trial population and addresses related issues. (Generally, a developer of a new drug or device may seek an investigational use exemption to facilitate clinical investigations, as part of the process to obtain approval to sell that drug or device.) Specifically, the Food and Drug Administration (FDA) must issue regulations to require applications for such exemptions to include certain information, including (1) demographic data disaggregated by subgroup, where such data is available, about the expected or potential patient population; (2) the applicant's enrollment targets for the clinical trials involved, disaggregated by age group, sex, race, and ethnicity; (3) a diversity plan for how the applicant will meet these targets; and (4) what is known about the patient population, such as comorbidities. The regulations must also require certain applicant reports to the FDA to address issues related to demographic diversity in clinical trials and product safety and effectiveness for demographic subgroups. The bill also authorizes the FDA to, in certain instances, require additional studies or surveillance after a drug or device has been approved if the clinical trials used in the application process did not meet the demographic enrollment targets.
United States · United States Congress · 3 February 2022
Algorithmic Accountability Act of 2022 This bill requires certain businesses that use automated decision systems to make critical decisions to study and report about the impact of those systems on consumers. Critical decisions include those that have a significant effect on a consumer's life such as the cost or availability of health care, housing, educational opportunities, or financial services. The Federal Trade Commission (FTC), in consultation with relevant stakeholders, must issue regulations to implement the bill. The bill provides for enforcement by the FTC and specified state officials. Further, the bill establishes a Bureau of Technology to advise the FTC about the technological aspects of its functions.
United States · United States Congress · 3 February 2022
Algorithmic Accountability Act of 2022 This bill requires certain businesses that use automated decision systems to make critical decisions to study and report about the impact of those systems on consumers. Critical decisions include those that have a significant effect on a consumer's life such as the cost or availability of health care, housing, educational opportunities, or financial services. The Federal Trade Commission (FTC), in consultation with relevant stakeholders, must issue regulations to implement the bill. The bill provides for enforcement by the FTC and specified state officials. Further, the bill establishes a Bureau of Technology to advise the FTC about the technological aspects of its functions.
United States · United States Congress · 3 February 2022
Help Expand Liability Protections for Volunteers Act or the HELP for Volunteers Act This bill makes permanent liability protections for health care professionals who volunteer their services at community health centers.
United States · United States Congress · 3 February 2022
Natural Immunity Transparency Act This bill requires the Department of Health and Human Services to report within 30 days of the bill's enactment to Congress concerning natural immunity to COVID-19. In particular, the report must compare certain outcomes for individuals who recovered from a COVID-19 infection without having received the vaccination and individuals who received the vaccination.
United States · United States Congress · 3 February 2022
Accelerated Drug Approval for Prescription Therapies 2.0 Act or the ADAPT 2.0 Act This bill allows applicants seeking Food and Drug Administration (FDA) approval to market a new drug to rely on investigations conducted in certain other countries and addresses related issues. If an applicant seeks market approval for a new drug with an application that relies on at least one investigation that the applicant did not conduct and did not obtain approval to use, the applicant may rely on an investigation that was conducted in certain foreign countries if the drug in question has already been approved in that country. The investigation must have been conducted in Australia, Canada, Israel, Japan, New Zealand, Switzerland, South Africa, the United Kingdom, the European Union, a country in the European Economic Area, or another country that the FDA has found to meet certain requirements. The FDA must make a decision on such an application within 90 days of the application's filing. If the FDA does not take certain actions within that period, the application shall be considered approved. The FDA may require the applicant to conduct postapproval studies of the drug and to submit copies of all promotional materials. The bill also establishes an advisory committee to provide the FDA with recommendations as to each application that relies on a foreign investigation. The FDA must make available on its public website each decision on such an application, including the rationale for the decision and the advisory committee's recommendations.
United States · United States Congress · 2 February 2022
Small Practice, Underserved, and Rural Support Program Extension Act of 2022 or the SURS Extension Act This bill reauthorizes funds through FY2027 for the Centers for Medicare & Medicaid Services to contract with specified entities (e.g., quality improvement organizations) to provide technical assistance regarding the Merit-based Incentive Payment System (MIPS) and alternative payment models under Medicare, specifically for health professionals in practices with 15 or fewer professionals. (MIPS is an incentive program under Medicare that allows health professionals to receive payment adjustments based on certain performance measures.)
United States · United States Congress · 2 February 2022
Striking Workers Healthcare Protection Act This bill prohibits an employer from terminating or significantly altering the employer-provided health insurance coverage of an employee engaged in a lawful strike. An employer that violates this prohibition is subject to a maximum civil penalty of $50,000 for each violation.
United States · United States Congress · 2 February 2022
Kids in Classes Act This bill prohibits a state educational agency from receiving specified federal education funds unless funds are provided directly to a parent or guardian of an eligible child for certain qualified educational expenses (e.g., educational materials, tutoring, or private school tuition). Eligible child refers to a child who attends a public elementary or secondary school and such school (1) receives specified federal education funds; and (2) does not provide, for more than three days during a school year and for reasons related to a public health emergency or collective bargaining action, in-person instruction for all students who wish to attend.
United States · United States Congress · 2 February 2022
Kids in Classes Act This bill prohibits a state educational agency from receiving specified federal education funds unless funds are provided directly to a parent or guardian of an eligible child for certain qualified educational expenses (e.g., educational materials, tutoring, or private school tuition). Eligible child refers to a child who attends a public elementary or secondary school and such school (1) receives specified federal education funds; and (2) does not provide, for more than three days during a school year and for reasons related to a public health emergency or collective bargaining action, in-person instruction for all students who wish to attend.
United States · United States Congress · 2 February 2022
Agility in Manufacturing Preparedness Act This bill requires the Department of Health and Human Services (HHS) to seek to contract with the National Institute for Innovation in Manufacturing Biopharmaceuticals to assess and make recommendations concerning U.S. capabilities for biopharmaceutical manufacturing and related matters. HHS must coordinate with the Biomedical Advanced Research and Development Authority on this contract.
United States · United States Congress · 2 February 2022
Improving Trauma Systems and Emergency Care Act This bill reauthorizes through FY2027 and modifies activities of the Department of Health and Human Services related to trauma care. Specific changes include requiring the Office of the Assistant Secretary for Preparedness and Response to develop guidance for and otherwise support states (and consortia of states) to coordinate and improve emergency medical services and trauma care during declared emergencies. The bill also expands eligibility for and revises (1) grants for improving emergency medical services and trauma care in rural areas, and (2) competitive grants for improving regional emergency medical and trauma systems.
United States · United States Congress · 2 February 2022
Small Practice, Underserved, and Rural Support Program Extension Act of 2022 or the SURS Extension Act This bill reauthorizes funds through FY2027 for the Centers for Medicare & Medicaid Services to contract with specified entities (e.g., quality improvement organizations) to provide technical assistance regarding the Merit-based Incentive Payment System (MIPS) and alternative payment models under Medicare, specifically for health professionals in practices with 15 or fewer professionals. (MIPS is an incentive program under Medicare that allows health professionals to receive payment adjustments based on certain performance measures.)
United States · United States Congress · 2 February 2022
No Taxpayer Dollars for Communist China COVID Tests Act This bill prohibits the use of federal funds to procure at-home COVID-19 tests that are imported from or manufactured (in whole or in part) in China.
United States · United States Congress · 1 February 2022
Veterans Hearing Benefits Act of 2022 This bill provides a presumption of service-connection for hearing-related issues in certain veterans for purposes of wartime disability compensation. Under a presumption of service-connection, specific conditions diagnosed in certain veterans are presumed to have been caused by the circumstances of their military service. Health care benefits and disability compensation may then be awarded. Per the bill, certain veterans with diagnosed hearing loss, tinnitus, or both shall be presumed to have incurred or aggravated such conditions during active military, naval, or air service. This bill applies to veterans who (1) served in combat, or (2) were assigned to a military occupational specialty that likely exposed them to a sufficiently high level of acoustic trauma. The bill also requires the Department of Veterans Affairs to adjust the schedule of rating disabilities to establish a minimum disability rating for a veteran who requires a hearing aid because of a service-connected disability.
United States · United States Congress · 1 February 2022
Health Care for Burn Pit Veterans Act This bill updates policies and procedures related to Department of Veterans Affairs (VA) health care and benefits for veterans who have been exposed to toxic substances. Specifically, the bill extends the eligibility period for VA hospital care, medical services, and nursing home care for combat veterans who served after September 11, 2001, and were exposed to toxic substances, radiation, or other conditions, including those who did not enroll to receive VA care during the eligibility period. The VA must incorporate into its existing health care screening a screening to help determine potential exposures to toxic substances during military service. Among other requirements, the VA must also provide annual training to health care and benefits personnel with respect to veterans who were exposed to toxic substances; analyze total and respiratory disease mortality in veterans who served in specified locations on specified dates; conduct an epidemiological study on the health trends of veterans who served in the Armed Forces after September 11, 2001; conduct a study to determine trends in the rates of the incidence of cancer in veterans; publish a list of VA resources for veterans who were exposed to toxic substances, families and caregivers of such veterans, and survivors of such veterans who are receiving death benefits; and report on the data quality of the Individual Longitudinal Exposure Record and its usefulness in supporting veterans in receiving VA health care and benefits.
United States · United States Congress · 1 February 2022
Respecting the Rights of Organ Donor Recipients Act of 2022 This bill prohibits limiting access to organ transplants based on an individual's COVID-19 vaccination status. Specifically, the Organ Procurement and Transplantation Network may not (1) request an individual's COVID-19 vaccination status when considering whether to place the individual on an organ transplant waitlist, or (2) require the vaccination in order for an individual to receive an organ transplant. This network is a public-private partnership that links organizations (e.g., transplantation centers and laboratories) in the organ donation and transplantation system.
United States · United States Congress · 1 February 2022
Protecting Americans from Unsafe Drugs Act of 2022 This bill expands the authority of the Secretary of the Department of Health and Human Services (HHS) to order the recall of controlled substances to cover all drugs. Furthermore, the authority to issue such an order may be delegated to the Director of the Center for Drug Evaluation and Research or the Director of the Center for Biologics Evaluation and Research (or an official senior to either director), whereas currently this authority may only be delegated to the Director of the Center for Drug Evaluation and Research or an official senior to such director. (Both centers are located in the Food and Drug Administration within HHS.)
United States · United States Congress · 1 February 2022
Stop Arduous Vaccine Enforcement Act of 2022 or the SAVE Act of 2022 This bill prohibits transplant centers from discriminating against an individual on the basis of COVID-19 vaccination status for purposes of determining eligibility or assigning priority for organ transplants.
United States · United States Congress · 31 January 2022
Tracking Pathogens Act This bill requires the Centers for Disease Control and Prevention (CDC) to take specified actions related to the genomic sequencing of pathogens. Specifically, the CDC must issue guidance on sharing specimens and other activities to support collaboration in the genomic sequencing of pathogens. The CDC must also strengthen and expand activities related to the use of genomic sequencing of pathogens in public health surveillance, including by providing technical assistance to health departments. The CDC may award grants, contracts, or cooperative agreements to academic and other laboratories related to these activities. In addition, the CDC must establish through public health agencies (or partnerships of such agencies) centers of excellence to promote innovation in pathogen genomics and molecular epidemiology.
United States · United States Congress · 28 January 2022
Medical Innovation Acceleration Act of 2022 This bill exempts noninvasive diagnostic devices from the regulatory authority of the Food and Drug Administration. The bill defines noninvasive diagnostic device as one that does not penetrate the skin or any other membrane of the body, is not inserted or implanted into the body, causes no more than ephemeral compression or temperature changes to in situ bodily tissues, and does not subject bodily tissues to ionizing radiation.
United States · United States Congress · 28 January 2022
Prescription Freedom Act of 2022 This bill generally eliminates the authority of the Food and Drug Administration (FDA) to require that a drug be dispensed only with a prescription. However, the FDA may continue to require a prescription for any drug intended for terminating a pregnancy.
United States · United States Congress · 28 January 2022
Access to AEDs Act This bill requires the Department of Health and Human Services to award grants to local educational agencies and private elementary and secondary schools, in partnership with a health care entity, to promote student access to defibrillation in elementary and secondary schools.
United States · United States Congress · 28 January 2022
Patients' Right to Know Their Medication Act of 2022 This bill requires the Food and Drug Administration (FDA) to issue regulations concerning the patient medication information that is included in the labeling for prescription medications. The regulations must impose various requirements, such as requiring the information to (1) be scientifically accurate and approved by the FDA; (2) include general directions for proper use and warnings that are written in understandable plain language; (3) contain information about known clinically important interactions with drugs, food, and other substances; (4) include a statement of whether there is sufficient data about the drug's use by specified subpopulations, such as children or pregnant women; and (5) be provided in a printed format with each prescription dispensed. The bill prohibits prescription medications that fail to meet this bill's requirements.